MACCURA BIOTECHNOLOGY CO.LTD Maccura Biotechnology Co.Ltd Stock
Equities
300463
CNE1000020H3
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.73 CNY | +1.27% |
|
+9.18% | -15.53% |
| 04-25 | Maccura Biotechnology Co.Ltd Proposes Final Cash Dividend for the Year 2023 | CI |
| 04-24 | Maccura Biotechnology Co.Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Sales 2024 * | 3.1B 427M 584M | Sales 2025 * | 3.51B 484M 661M | Capitalization | 7.8B 1.08B 1.47B |
|---|---|---|---|---|---|
| Net income 2024 * | 437M 60.31M 82.36M | Net income 2025 * | 605M 83.49M 114M | EV / Sales 2024 * | 2.52 x |
| Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 2.22 x |
| P/E ratio 2024 * |
17.9
x | P/E ratio 2025 * |
12.9
x | Employees | 3,016 |
| Yield 2024 * |
2.2% | Yield 2025 * |
3.3% | Free-Float | 61.17% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.27% | ||
| 1 week | +9.18% | ||
| Current month | +0.55% | ||
| 1 month | +1.60% | ||
| 3 months | -1.93% | ||
| 6 months | -18.14% | ||
| Current year | -15.53% |
1 week
11.83
12.76
1 month
11.4013.18
Current year
9.9015.23
1 year
9.9017.40
3 years
9.9049.34
5 years
9.9065.24
10 years
9.9065.24
| Managers | Title | Age | Since |
|---|---|---|---|
Ming Jian Wu
CEO | Chief Executive Officer | 49 | 01-12-31 |
Shan Yin
DFI | Director of Finance/CFO | 44 | 21-10-25 |
Yong Tang
CHM | Chairman | 60 | 94-10-19 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Dai Guo Fu
BRD | Director/Board Member | 60 | 19-01-21 |
Yong Tang
CHM | Chairman | 60 | 94-10-19 |
Qi Lin Liu
BRD | Director/Board Member | 57 | 93-12-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 12.73 | +1.27% | 5,836,000 |
| 24-04-25 | 12.57 | +3.63% | 8,292,144 |
| 24-04-24 | 12.13 | +0.92% | 2,669,366 |
| 24-04-23 | 12.02 | +0.84% | 4,089,861 |
| 24-04-22 | 11.92 | +2.23% | 6,193,587 |
End-of-day quote Shenzhen S.E., April 25, 2024
More quotes
Maccura Biotechnology Co., Ltd., formerly Sichuan Maccura Biotechnology Co., Ltd., is a China-based company principally engaged in research, development, manufacture and sales of in-vitro diagnostics products and the sales of in-vitro diagnostic products of foreign brands as an agent. The Company provides hundreds of products which cover clinical biochemistry, chemiluminescent immunoassay, rapid diagnosis, thrombosis, hemostasis, and molecular diagnosis.
Calendar
2024-07-31
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
C+
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
12.73
CNY
Average target price
15.46
CNY
Spread / Average Target
+21.45%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -15.53% | 1.08B | |
| +1.09% | 12.8B | |
| -10.29% | 7.61B | |
| -1.16% | 4.51B | |
| +5.74% | 4.49B | |
| -50.70% | 3.3B | |
| +12.21% | 2.73B | |
| -14.89% | 2.02B | |
| -11.50% | 1.73B | |
| -5.02% | 1.64B |
- Stock Market
- Equities
- 300463 Stock
